Inhibition of Novel GCN5-ATM Axis Restricts the Onset of Acquired Drug Resistance in Leukemia

International Journal of Cancer - United States
doi 10.1002/ijc.31242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inhibition of EZH2 Degradation as a Novel Approach to Overcome Drug Resistance in Acute Myeloid Leukemia

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2017English

LncRNA ZEB2-AS1 Regulates the Drug Resistance of Acute Myeloid Leukemia via the miR-142-3p/INPP4B Axis

RSC Advances
ChemistryChemical Engineering
2019English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research
Cancer ResearchOncology
2011English

Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments

2019English

Histone Deacetylase 1 Induced by Neddylation Inhibition Contributes to Drug Resistance in Acute Myelogenous Leukemia

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2019English

Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas

Oncotarget
Oncology
2016English

Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2012English

Drug-Resistance Enables Selective Killing of Resistant Leukemia Cells: Exploiting of Drug Resistance Instead of Reversal

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy